PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31360147-0	2019	Ameliorative Effect of Berberine on Neonatally Induced Type 2 Diabetic Neuropathy via Modulation of BDNF, IGF-1, PPAR-gamma, and AMPK Expressions.	Berberine	23-32	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	129-133	
31360147-11	2019	Western blot analysis revealed that STZ-induced alterations in adenosine monophosphate protein kinase (AMPK; Thr-172) and protein phosphatase 2C-alpha protein expressions in dorsal root ganglia were inhibited by berberine.	Berberine	212-221	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	103-107	
31360147-13	2019	In conclusion, berberine exerts its neuroprotective effect against n-STZ-induced diabetic peripheral neuropathy via modulation of pro-inflammatory cytokines (TNF alpha, IL-1beta, and IL-6), oxido-nitrosative stress, BDNF, IGF-1, PPAR-gamma, and AMPK expression to ameliorate impaired allodynia, hyperalgesia, and nerve conduction velocity during T2DM.	Berberine	15-24	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	245-249